Posted inBiotechnology
Efficacy Longevity of 2024-2025 COVID-19 Vaccines Against Emerging JN.1 Subvariants
The ongoing global battle against COVID-19 has entered a new chapter with the introduction of the updated 2024-2025 vaccines, which…
Posted inBiotechnology
Why Protocol-Ready Doesn’t Mean Trial-Ready in Ovarian Cancer Clinical Trials
Roughly 70 to 80% of ovarian cancer cases are diagnosed at an advanced stage,1 where treatment options are limited and…
Posted inBiotechnology
2025 M&A up in value and deal count after year of ‘conservatism and recovery’: Leerink Partners
The number of biopharma M&A deals announced so far this year is higher than the yearly average for the last…
Posted inBiotechnology
Navigating Alexithymia and Emotions in Nursing Students
In the ever-evolving landscape of psychological research, a groundbreaking study undertaken by Sun, Wang, Hu, and colleagues shines a critical…
Posted inBiotechnology
Intellia pauses phase 3 CRISPR trials after patient is hospitalized
Intellia Therapeutics has temporarily paused dosing and screening in a pair of phase 3 trials in response to a liver safety…
Posted inBiotechnology
Sarcopenia: The Future of Muscle Ultrasound?
The relentless march of aging carries with it a plethora of challenges, chief among them being sarcopenia, a condition characterized…
Posted inBiotechnology
Serum Phosphate Levels Link to Hospital Stay in Neonatal Sepsis
A recent study published in BMC Pediatrics has shed light on a crucial aspect of neonatal care that may have…
Posted inBiotechnology
Zenas’ autoimmune drug prompts 95% reduction in new brain lesions in phase 2 MS study
Zenas Biopharma’s autoimmune drug candidate has been tied to a 95% reduction in a type of brain lesions over 12…
Posted inBiotechnology
Exploring Cathepsin Z’s Role in Prostate Cancer
Recent studies have illuminated the multifaceted role of cathepsin Z in prostate cancer, a topic that has sparked intense discussion…
Posted inBiotechnology
Revealing Hyper-Maturity and Rapid Aging in the Hippocampus
In a groundbreaking revelation poised to reshape our understanding of neuropsychiatric disorders, researchers at Fujita Health University and the Tokyo…